{"slideshow_credits": null, "snippet": "In rejecting Valeant\u2019s latest offer, Allergan trumpeted its research. Valeant, responding on Wednesday, said that most successful pharmaceutical innovation comes from smaller, more nimble competitors.", "abstract": "In rejecting Valeant\u2019s latest offer, Allergan trumpeted its research. Valeant, responding on Wednesday, said that most successful pharmaceutical innovation comes from smaller, more nimble competitors.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "GELLES", "rank": 1, "organization": ""}], "original": "By DAVID GELLES"}, "web_url": "http://dealbook.nytimes.com/2014/06/11/in-bid-for-botox-maker-valeant-defends-its-record-on-research/", "lead_paragraph": null, "headline": {"main": "In Bid for Botox Maker, Valeant Defends Its Record on Research", "kicker": "DealBook"}, "_id": "53988d8f38f0d81d3bbc1556", "word_count": "516", "multimedia": [{"height": 126, "url": "images/2014/06/11/business/dbpix-valleant/dbpix-valleant-thumbWide.png", "legacy": {"wideheight": "126", "wide": "images/2014/06/11/business/dbpix-valleant/dbpix-valleant-thumbWide.png", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 417, "url": "images/2014/06/12/business/dbpix-valeant1/dbpix-valeant1-articleLarge.jpg", "legacy": {"xlarge": "images/2014/06/12/business/dbpix-valeant1/dbpix-valeant1-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "417"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/06/11/business/dbpix-valleant/dbpix-valleant-thumbStandard.png", "legacy": {"thumbnail": "images/2014/06/11/business/dbpix-valleant/dbpix-valleant-thumbStandard.png", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-06-11T13:09:56Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "persons", "value": "Jobs, Steven P", "rank": "1"}, {"name": "organizations", "value": "Apple Inc", "rank": "2"}, {"name": "organizations", "value": "International Business Machines Corporation", "rank": "3"}, {"name": "organizations", "value": "Securities and Exchange Commission", "rank": "4"}, {"name": "organizations", "value": "Allergan Inc", "rank": "1"}, {"name": "subject", "value": "Research", "rank": "3"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}